Home > Cashflow Statement > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Cashflow Statement

ASPIRA PATHLAB & DIAGNOSTICS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024
Profit Before Tax₹2.02 Cr₹-2.67 Cr
Adjustment ₹1.78 Cr₹1.77 Cr
Changes In working Capital ₹-1.97 Cr₹1.96 Cr
Cash Flow after changes in Working Capital ₹1.83 Cr₹1.05 Cr
Cash Flow from Operating Activities ₹1.83 Cr₹1.05 Cr
Cash Flow from Investing Activities ₹0.12 Cr₹0.14 Cr
Cash Flow from Financing Activities ₹-0.99 Cr₹-0.95 Cr
Net Cash Inflow / Outflow ₹0.95 Cr₹0.24 Cr
Opening Cash & Cash Equivalents ₹0.80 Cr₹0.57 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --
Cash & Cash Equivalent of Subsidiaries under liquidations --
Translation adjustment on reserves / op cash balalces frgn subsidiaries --
Effect of Foreign Exchange Fluctuations --
Closing Cash & Cash Equivalent ₹1.75 Cr₹0.80 Cr

Compare Cashflow Statement of peers of ASPIRA PATHLAB & DIAGNOSTICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS ₹134.9 Cr NA 6.1% 126.1% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹132,139.0 Cr 5% 21.1% 16.8% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹105,080.0 Cr 6.9% 32.7% -7.5% Stock Analytics
ASTER DM HEALTHCARE ₹67,959.9 Cr 3.8% 19.2% 9% Stock Analytics
FORTIS HEALTHCARE ₹62,284.1 Cr 2.9% 14% -14.3% Stock Analytics
NARAYANA HRUDAYALAYA ₹39,757.4 Cr 2.7% 14.9% -7.6% Stock Analytics


ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS NA

6.1%

126.1%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses